Strategies in cancer vaccines development
- 5 April 2003
- journal article
- review article
- Published by Elsevier in International Journal for Parasitology
- Vol. 33 (5-6) , 597-613
- https://doi.org/10.1016/s0020-7519(03)00054-7
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Aspects of cancer immunotherapyImmunology & Cell Biology, 2003
- A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapyGene Therapy, 2002
- Immunization with a carbohydrate mimicking peptide augments tumor-specific cellular responsesInternational Immunology, 2001
- From cancer genomics to cancer immunotherapy: toward second-generation tumor antigensTrends in Immunology, 2001
- Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancerBone Marrow Transplantation, 2000
- Helminth C-type Lectins and Host–Parasite InteractionsParasitology Today, 2000
- CD1—A New Paradigm for Antigen Presentation and T Cell ActivationClinical Immunology and Immunopathology, 1998
- Peptide Mimicry of Adenocarcinoma-Associated Carbohydrate AntigensHybridoma, 1997
- T/Tn Antigen Vaccine is Effective and Safe in Preventing Recurrence of Advanced Human Breast CarcinomaCancer Biotherapy, 1994
- Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvantCancer Immunology, Immunotherapy, 1993